Dasatinib Shows Potential to Treat Rare Type of Ovarian Cancer

Dasatinib Shows Potential to Treat Rare Type of Ovarian Cancer
Dasatinib, a drug approved for the treatment of patients with leukemia, could also be used to treat ovarian clear cell carcinoma, a rare form of ovarian cancer. These are the conclusions of a study titled “Synthetic Lethal Targeting of ARID1A mutant ovarian clear cell tumours with dasatinib,” published in the journal Molecular Cancer Therapeutics. Ovarian clear cell carcinoma

Knowledge is power when living with ovarian cancer.

Get access to the web’s leading Ovarian Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *